Filtros : "Palei, Ana C. T" Limpar

Filtros



Refine with date range


  • Source: Pregnancy Hypertension. Unidade: FMRP

    Subjects: ÓXIDO NÍTRICO, NITRITOS, PRÉ-ECLÂMPSIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PEREIRA, Daniela A et al. NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia. Pregnancy Hypertension, v. 18, p. 137-140, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.preghy.2019.09.022. Acesso em: 08 maio 2024.
    • APA

      Pereira, D. A., Sandrim, V. C., Palei, A. C. T., Tanus-Santos, J. E., Belo, V. A., Cavalli, R. de C., & Luizon, M. R. (2019). NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia. Pregnancy Hypertension, 18, 137-140. doi:10.1016/j.preghy.2019.09.022
    • NLM

      Pereira DA, Sandrim VC, Palei ACT, Tanus-Santos JE, Belo VA, Cavalli R de C, Luizon MR. NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia [Internet]. Pregnancy Hypertension. 2019 ; 18 137-140.[citado 2024 maio 08 ] Available from: https://doi.org/10.1016/j.preghy.2019.09.022
    • Vancouver

      Pereira DA, Sandrim VC, Palei ACT, Tanus-Santos JE, Belo VA, Cavalli R de C, Luizon MR. NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia [Internet]. Pregnancy Hypertension. 2019 ; 18 137-140.[citado 2024 maio 08 ] Available from: https://doi.org/10.1016/j.preghy.2019.09.022
  • Source: Pharmacogenomics. Unidade: FMRP

    Subjects: FARMACOGENÉTICA, HIPERTENSÃO NA GRAVIDEZ, PRÉ-ECLÂMPSIA, HIPERTENSÃO, POLIMORFISMO, GENÓTIPOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LUIZON, Marcelo R et al. Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives. Pharmacogenomics, v. 18, n. 6, p. 571-583, 2017Tradução . . Disponível em: https://doi.org/10.2217/pgs-2016-0198. Acesso em: 08 maio 2024.
    • APA

      Luizon, M. R., Palei, A. C. T., Cavalli, R. de C., & Sandrim, V. C. (2017). Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives. Pharmacogenomics, 18( 6), 571-583. doi:10.2217/pgs-2016-0198
    • NLM

      Luizon MR, Palei ACT, Cavalli R de C, Sandrim VC. Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives [Internet]. Pharmacogenomics. 2017 ; 18( 6): 571-583.[citado 2024 maio 08 ] Available from: https://doi.org/10.2217/pgs-2016-0198
    • Vancouver

      Luizon MR, Palei ACT, Cavalli R de C, Sandrim VC. Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives [Internet]. Pharmacogenomics. 2017 ; 18( 6): 571-583.[citado 2024 maio 08 ] Available from: https://doi.org/10.2217/pgs-2016-0198
  • Source: Journal of Cellular and Molecular Medicine. Unidade: FMRP

    Subjects: PRÉ-ECLÂMPSIA (EXPERIMENTAÇÃO), ÓXIDO NÍTRICO, ESTRESSE OXIDATIVO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AMARAL, Lorena M et al. Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia. Journal of Cellular and Molecular Medicine, v. 17, n. 10, p. 1300-1307, 2013Tradução . . Disponível em: https://doi.org/10.1111/jcmm.12106. Acesso em: 08 maio 2024.
    • APA

      Amaral, L. M., Pinheiro, L. C., Guimarães, D. A., Palei, A. C. T., Sertório, J. T., Portella, R. L., & Tanus-Santos, J. E. (2013). Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia. Journal of Cellular and Molecular Medicine, 17( 10), 1300-1307. doi:10.1111/jcmm.12106
    • NLM

      Amaral LM, Pinheiro LC, Guimarães DA, Palei ACT, Sertório JT, Portella RL, Tanus-Santos JE. Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia [Internet]. Journal of Cellular and Molecular Medicine. 2013 ; 17( 10): 1300-1307.[citado 2024 maio 08 ] Available from: https://doi.org/10.1111/jcmm.12106
    • Vancouver

      Amaral LM, Pinheiro LC, Guimarães DA, Palei ACT, Sertório JT, Portella RL, Tanus-Santos JE. Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia [Internet]. Journal of Cellular and Molecular Medicine. 2013 ; 17( 10): 1300-1307.[citado 2024 maio 08 ] Available from: https://doi.org/10.1111/jcmm.12106

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024